Biodexa Prices $3.5 Mln Offering Of Shares And Concurrent Private Placement Of Warrants; Stock Down

Biodexa Pharmaceuticals PLC (BDRX), a clinical-stage biopharmaceutical company, announced the pricing of a $0.8 million registered offering, a $1 million concurrent private placement and a $1.